3Torres-Quevedo R., Manterola C., Sanhueza A. et al. Diagnostic properties of a symptoms scale for diagnosing reflux esophagitis [J]. Journal of Clinical Epidemiology. 2009, 62: 97-101.
4许国鈱,李兆申.上消化道内镜学[M].上海科学技术出版社,2003.235-245.
5Stedman CA., Barclay ML., Revieraticle, comparison of the pharmacokinetica, acid suppression and efficacy of proton pump inhibitors[J]. Aliment pharmacol Ther, 2000, 14 (8) : 963-978.
6Ariizumi K., Ohars S., Koike T., et al. Therapeutic effects of 10mg/day raberazole administration on reflux esophagitis was not influenced by the CYP2C19 polymorphism[J]. J Gastroenterol Hepatol, 2006, 21 (9): 1428-1434.
7El-Omar EM,Carrington M,Chow WH,et al.Interleukin-1 polymorphisms associated with increased risk of gastric cancer.Nature,2000,404(6776):398-402.
8Shibata J,Goto H,Arisawa T,et al.Regulation of tumour necro-sis factor (TNF) induced apoptosis by soluble TNF receptors in helicobacter pylori infection.Gut,1999,45(1):24-31.
